サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1729264

日本の抗生物質市場レポート：作用機序、薬剤クラス別、活性スペクトル、投与経路、エンドユーザー、地域別、2025年～2033年

Japan Antibiotics Market Report by Action Mechanism, Drug Class, Spectrum of Activity, Route of Administration, End User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 118 Pages
納期
5～7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.36円
日本の抗生物質市場レポート：作用機序、薬剤クラス別、活性スペクトル、投与経路、エンドユーザー、地域別、2025年～2033年
出版日: 2025年05月01日
発行: IMARC
ページ情報: 英文 118 Pages
納期: 5～7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

日本の抗生物質の市場規模は2024年に31億5,200万米ドルに達しました。今後、IMARC Groupは、同市場が2033年までに58億5,100万米ドルに達し、2025～2033年の成長率（CAGR）は7.1％に達すると予測しています。手術、医療処置、入院にもつながる感染症の蔓延が拡大しており、その結果、そのような状態を予防・治療するための抗生物質の必要性が高まっていることが、主に市場を牽引しています。

本レポートで扱う主な質問

  • 日本の抗生物質市場はこれまでどのように推移し、今後どのように推移していくのか？
  • COVID-19が日本の抗生物質市場に与えた影響は？
  • 日本の抗生物質市場の作用機序別の区分は？
  • 薬剤クラス別の日本の抗生物質市場の内訳は？
  • 活性スペクトル別の日本の抗生物質市場内訳は？
  • 日本の抗生物質市場の投与経路別の区分は？
  • 日本の抗生物質市場のエンドユーザー別の区分は？
  • 日本の抗生物質市場のバリューチェーンにおける様々な段階とは？
  • 日本の抗生物質の主な促進要因と課題は何か？
  • 日本の抗生物質市場の構造と主要プレーヤーは？
  • 日本の抗生物質市場における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
  • 市場推定
  • 調査手法

第3章 エグゼクティブサマリー

第4章 日本の抗生物質市場- イントロダクション

  • 概要
  • 市場力学
  • 業界動向
  • 競合情報

第5章 日本の抗生物質市場情勢

  • 過去および現在の市場動向（2019～2024年）
  • 市場予測（2025～2033年）

第6章 日本の抗生物質市場- 作用機序別の内訳

  • 細胞壁合成阻害剤
  • タンパク質合成阻害剤
  • DNA合成阻害剤
  • RNA合成阻害剤
  • ミコール酸阻害剤
  • その他

第7章 日本の抗生物質市場- 薬剤クラス別の内訳

  • セファロスポリン
  • ペニシリン
  • フルオロキノロン
  • マクロライド
  • カルバペネム
  • アミノグリコシド
  • その他

第8章 日本の抗生物質市場- 活性スペクトル別の内訳

  • 広域スペクトル抗生物質
  • 狭域スペクトル抗生物質

第9章 日本の抗生物質市場- 投与経路別の内訳

  • 経口
  • 非経口
  • 外用
  • その他

第10章 日本の抗生物質市場- エンドユーザー別の内訳

  • 病院
  • 専門クリニック
  • その他

第11章 日本の抗生物質市場- 競合情勢

  • 概要
  • 市場構造
  • 市場企業のポジショニング
  • 主要成功戦略
  • 競合ダッシュボード
  • 企業評価象限

第12章 主要企業のプロファイル

第13章 日本の抗生物質市場- 業界分析

  • 促進要因、抑制要因、機会
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第14章 付録

目次
Product Code: SR112025A18083

Japan antibiotics market size reached USD 3,152 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 5,851 Million by 2033, exhibiting a growth rate (CAGR) of 7.1% during 2025-2033. The escalating prevalence of infectious diseases, which also leads to surgeries, medical procedures, and hospitalizations, thereby increasing the need for antibiotics to prevent and treat such conditions, is primarily driving the market.

Antibiotics are powerful medications used to treat bacterial infections. They work by targeting and killing bacteria or inhibiting their growth. Antibiotics can be categorized into several classes, each with its unique mechanism of action. They are prescribed by healthcare professionals after diagnosing a bacterial infection. It's crucial to use antibiotics as directed and complete the prescribed course to ensure the complete eradication of bacteria. Failure to do so can lead to antibiotic resistance, where bacteria become less responsive to these drugs. While antibiotics are effective against bacteria, they do not work on viral infections like the common cold or flu. Overuse or misuse of antibiotics has raised concerns about the development of antibiotic-resistant strains of bacteria, making it essential to use them judiciously and only when necessary. Research into new antibiotics and alternative treatments continues to be a critical area of focus in healthcare to combat evolving bacterial threats.

Japan Antibiotics Market Trends:

The antibiotics market in Japan has witnessed significant growth over the years, and several key drivers have propelled this upward trajectory. Firstly, the rise in bacterial infections has necessitated an increased demand for antibiotics. Additionally, the expansion of the geriatric population, which is more susceptible to infections, has further fueled this need. Moreover, advancements in biotechnological methods have led to the discovery of novel antibiotics, thus expanding the market. Furthermore, the spread of antibiotic-resistant pathogens has created an urgency to invest in R&D, leading to more innovations and developments in the sector. Notably, the increasing support and funding from both government and private entities have been pivotal in pushing forward research initiatives. Another crucial factor is the growing awareness among people about bacterial infections and their implications, coupled with easy access to healthcare facilities. Consequently, there is a steady growth in antibiotic prescriptions, boosting the market. On the other hand, though the need for effective treatment regimens is undeniable, there are concerns about antibiotic overuse, potentially causing resistance. Nevertheless, the overall need for effective antibacterial treatments remains paramount, and these market drivers play a crucial role in shaping the industry's landscape.

Japan Antibiotics Market Segmentation:

Action Mechanism Insights:

  • Cell Wall Synthesis Inhibitors
  • Protein Synthesis Inhibitors
  • DNA Synthesis Inhibitors
  • RNA Synthesis Inhibitors
  • Mycolic Acid Inhibitors
  • Others

Drug Class Insights:

  • Cephalosporin
  • Penicillin
  • Fluoroquinolone
  • Macrolide
  • Carbapenem
  • Aminoglycoside
  • Others

Spectrum of Activity Insights:

  • Broad-Spectrum Antibiotics
  • Narrow-Spectrum Antibiotics

Route of Administration Insights:

  • Oral
  • Parenteral
  • Topical
  • Others

End User Insights:

  • Hospitals
  • Specialty Clinics
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan antibiotics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan antibiotics market?
  • What is the breakup of the Japan antibiotics market on the basis of action mechanism?
  • What is the breakup of the Japan antibiotics market on the basis of drug class?
  • What is the breakup of the Japan antibiotics market on the basis of spectrum of activity?
  • What is the breakup of the Japan antibiotics market on the basis of route of administration?
  • What is the breakup of the Japan antibiotics market on the basis of end user?
  • What are the various stages in the value chain of the Japan antibiotics market?
  • What are the key driving factors and challenges in the Japan antibiotics?
  • What is the structure of the Japan antibiotics market and who are the key players?
  • What is the degree of competition in the Japan antibiotics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Antibiotics Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Antibiotics Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Antibiotics Market - Breakup by Action Mechanism

  • 6.1 Cell Wall Synthesis Inhibitors
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 Protein Synthesis Inhibitors
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)
  • 6.3 DNA Synthesis Inhibitors
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2019-2024)
    • 6.3.3 Market Forecast (2025-2033)
  • 6.4 RNA Synthesis Inhibitors
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2019-2024)
    • 6.4.3 Market Forecast (2025-2033)
  • 6.5 Mycolic Acid Inhibitors
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2019-2024)
    • 6.5.3 Market Forecast (2025-2033)
  • 6.6 Others
    • 6.6.1 Historical and Current Market Trends (2019-2024)
    • 6.6.2 Market Forecast (2025-2033)

7 Japan Antibiotics Market - Breakup by Drug Class

  • 7.1 Cephalosporin
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Penicillin
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)
  • 7.3 Fluoroquinolone
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2019-2024)
    • 7.3.3 Market Forecast (2025-2033)
  • 7.4 Macrolide
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2019-2024)
    • 7.4.3 Market Forecast (2025-2033)
  • 7.5 Carbapenem
    • 7.5.1 Overview
    • 7.5.2 Historical and Current Market Trends (2019-2024)
    • 7.5.3 Market Forecast (2025-2033)
  • 7.6 Aminoglycoside
    • 7.6.1 Overview
    • 7.6.2 Historical and Current Market Trends (2019-2024)
    • 7.6.3 Market Forecast (2025-2033)
  • 7.7 Others
    • 7.7.1 Historical and Current Market Trends (2019-2024)
    • 7.7.2 Market Forecast (2025-2033)

8 Japan Antibiotics Market - Breakup by Spectrum of Activity

  • 8.1 Broad-Spectrum Antibiotics
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 Narrow-Spectrum Antibiotics
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)

9 Japan Antibiotics Market - Breakup by Route of Administration

  • 9.1 Oral
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2019-2024)
    • 9.1.3 Market Forecast (2025-2033)
  • 9.2 Parenteral
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2019-2024)
    • 9.2.3 Market Forecast (2025-2033)
  • 9.3 Topical
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2019-2024)
    • 9.3.3 Market Forecast (2025-2033)
  • 9.4 Others
    • 9.4.1 Historical and Current Market Trends (2019-2024)
    • 9.4.2 Market Forecast (2025-2033)

10 Japan Antibiotics Market - Breakup by End User

  • 10.1 Hospitals
    • 10.1.1 Overview
    • 10.1.2 Historical and Current Market Trends (2019-2024)
    • 10.1.3 Market Forecast (2025-2033)
  • 10.2 Specialty Clinics
    • 10.2.1 Overview
    • 10.2.2 Historical and Current Market Trends (2019-2024)
    • 10.2.3 Market Forecast (2025-2033)
  • 10.3 Others
    • 10.3.1 Historical and Current Market Trends (2019-2024)
    • 10.3.2 Market Forecast (2025-2033)

11 Japan Antibiotics Market - Competitive Landscape

  • 11.1 Overview
  • 11.2 Market Structure
  • 11.3 Market Player Positioning
  • 11.4 Top Winning Strategies
  • 11.5 Competitive Dashboard
  • 11.6 Company Evaluation Quadrant

12 Profiles of Key Players

  • 12.1 Company A
    • 12.1.1 Business Overview
    • 12.1.2 Product Portfolio
    • 12.1.3 Business Strategies
    • 12.1.4 SWOT Analysis
    • 12.1.5 Major News and Events
  • 12.2 Company B
    • 12.2.1 Business Overview
    • 12.2.2 Product Portfolio
    • 12.2.3 Business Strategies
    • 12.2.4 SWOT Analysis
    • 12.2.5 Major News and Events
  • 12.3 Company C
    • 12.3.1 Business Overview
    • 12.3.2 Product Portfolio
    • 12.3.3 Business Strategies
    • 12.3.4 SWOT Analysis
    • 12.3.5 Major News and Events
  • 12.4 Company D
    • 12.4.1 Business Overview
    • 12.4.2 Product Portfolio
    • 12.4.3 Business Strategies
    • 12.4.4 SWOT Analysis
    • 12.4.5 Major News and Events
  • 12.5 Company E
    • 12.5.1 Business Overview
    • 12.5.2 Product Portfolio
    • 12.5.3 Business Strategies
    • 12.5.4 SWOT Analysis
    • 12.5.5 Major News and Events

13 Japan Antibiotics Market - Industry Analysis

  • 13.1 Drivers, Restraints and Opportunities
    • 13.1.1 Overview
    • 13.1.2 Drivers
    • 13.1.3 Restraints
    • 13.1.4 Opportunities
  • 13.2 Porters Five Forces Analysis
    • 13.2.1 Overview
    • 13.2.2 Bargaining Power of Buyers
    • 13.2.3 Bargaining Power of Suppliers
    • 13.2.4 Degree of Competition
    • 13.2.5 Threat of New Entrants
    • 13.2.6 Threat of Substitutes
  • 13.3 Value Chain Analysis

14 Appendix